BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26660168)

  • 1. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
    Garg U; Zhang YV
    Methods Mol Biol; 2016; 1383():1-10. PubMed ID: 26660168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
    Victoria Zhang Y; Garg U
    Methods Mol Biol; 2024; 2737():1-13. PubMed ID: 38036805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Chromatography-Tandem Mass Spectrometry: An Emerging Technology in the Toxicology Laboratory.
    Zhang YV; Wei B; Zhu Y; Zhang Y; Bluth MH
    Clin Lab Med; 2016 Dec; 36(4):635-661. PubMed ID: 27842783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Some thoughts on the links between LC-MS/MS and therapeutic drug monitoring].
    Saint-Marcoux F
    Ann Biol Clin (Paris); 2015; 73(1):49-53. PubMed ID: 25582722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and analytical toxicology of opiate, cocaine and amphetamine].
    Feliu C; Fouley A; Millart H; Gozalo C; Marty H; Djerada Z
    Ann Biol Clin (Paris); 2015; 73(1):54-69. PubMed ID: 25582723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring and LC-MS/MS.
    Adaway JE; Keevil BG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():33-49. PubMed ID: 21992751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS (/MS) in clinical toxicology screening methods.
    Viette V; Hochstrasser D; Fathi M
    Chimia (Aarau); 2012; 66(5):339-42. PubMed ID: 22867548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of point-of-care testing in the ED or ICU: a role for regional centralized toxicology laboratories.
    Wu AH
    Clin Pharmacol Ther; 2010 Sep; 88(3):295-8. PubMed ID: 20725077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry.
    de Albuquerque Cavalcanti G; Carius Garrido B; Dias Leal F; Costa Padilha M; Mazzarino M; de la Torre X; Botre F; Radler de Aquino Neto F
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):248-54. PubMed ID: 21924357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain Management Testing by Liquid Chromatography Tandem Mass Spectrometry.
    Bodor GS
    Clin Lab Med; 2018 Sep; 38(3):455-470. PubMed ID: 30115391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography tandem-mass spectrometry (LC-MS/MS)--technique and applications in endocrinology.
    Vogeser M; Parhofer KG
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):559-70. PubMed ID: 17943689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology.
    Marquet P
    Ther Drug Monit; 2002 Apr; 24(2):255-76. PubMed ID: 11897972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of liquid chromatography-high resolution mass spectrometry in toxicological screening].
    Li XW; Shen BH; Zhuo XY
    Fa Yi Xue Za Zhi; 2011 Oct; 27(5):376-81. PubMed ID: 22259869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of multiple drugs of abuse and metabolites in urine using LC/MS/MS with polarity switching electrospray ionization.
    Shin M; Ji D; Kang S; Yang W; Choi H; Lee S
    Arch Pharm Res; 2014 Jun; 37(6):760-72. PubMed ID: 23918650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories.
    Seger C
    Wien Med Wochenschr; 2012 Nov; 162(21-22):499-504. PubMed ID: 23129542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
    Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Stimulants and Narcotics by Liquid Chromatography-Tandem Mass Spectrometry and Gas Chromatography-Mass Spectrometry for Sports Doping Control.
    Ahrens BD; Kucherova Y; Butch AW
    Methods Mol Biol; 2016; 1383():247-63. PubMed ID: 26660193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology - An update.
    Remane D; Wissenbach DK; Peters FT
    Clin Biochem; 2016 Sep; 49(13-14):1051-71. PubMed ID: 27452180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.